Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures.
Single point mutations in parC are associated with reduced susceptibility to fluoroquinolones.
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America.
Mutations in gyrA and parC were associated with fluoroquinolone resistance.
Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification.
Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia.
Mutations where in vitro MIC determination has demonstrated significantly elevated MICs of moxifloxacin
Quinolone Resistance Reversion by Targeting the SOS Response.
Integrating the Human and Animal Sides of Mycoplasmas Resistance to Antimicrobials.
Mutations in parC are associated with fluoroquinolone resistance.
JMM Profile: Mycoplasma genitalium: a small, yet significant pathogen.
Quinolone resistance in Escherichia coli from Accra, Ghana.
Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC.
Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance Detection and Clinical Implications in a Selected Cohort in New Zealand.
Correlation between antibiotic resistance and phylogenetic types among multidrug-resistant Escherichia coli isolated from urinary tract infections.
Analysis of Neisseria gonorrhoeae and Mycoplasma genitalium from nucleic acid amplification test specimens, Nunavut region of Inuit Nunangat, Canada, 2020-2023.
Genetic characterization of fluoroquinolone-resistant Escherichia coli associated with bovine mastitis in India.
Molecular detection of Mycoplasma genitalium in endocervical swabs and associated rates of macrolide and fluoroquinolone resistance in Hong Kong.
Salmonella Typhi acquires diverse plasmids from other Enterobacteriaceae to develop cephalosporin resistance.
Estimation of antimicrobial resistance of Mycoplasma genitalium, Belgium, 2022.
Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli from the milk of cows with clinical mastitis in Southern Taiwan.
Management of Mycoplasma genitalium infections - can we hit a moving target?
Resistance to moxifloxacin and other fourth-generation quinolones is mediated by mutations in the quinolone resistance determining regions (QRDR) of the parC gene, primarily in the hotspots in amino acid positions S83 and D87.
Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far.
Detected in Salmonella isolates
Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.
Antimicrobial resistance in Mycoplasma genitalium sampled from the British general population.
Detection of Macrolide and/or Fluoroquinolone Resistance Genes in Mycoplasma genitalium Strains Isolated from Men in the Northwest Region of Croatia in 2018-2023.
Multidrug-resistant phenotypes of genetically diverse Escherichia coli isolates from healthy domestic cats.
Mycoplasma genitalium in Symptomatic Male Urethritis: Macrolide Use Is Associated With Increased Resistance.
Mutations in parC gene associated with fluoroquinolone resistance
A survey of antimicrobial-resistant Escherichia coli prevalence in wild mammals in Japan using antimicrobial-containing media.
Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.
Mutations in the parC gene were associated with fluoroquinolone resistance.
Mycoplasma genitalium and Antimicrobial Resistance Among a Cohort of West African Men Who Have Sex With Men Using Preexposure Prophylaxis (CohMSM-PrEP ANRS 12369-Expertise France Study).
Mutations in the quinolone resistance-determining region of parC
Prevalence of fluoroquinolone resistance-associated mutations in Mycoplasma genitalium among clients of two sexual health centres in the Netherlands: a cross-sectional study.
gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.
The S83I and D87N mutations in parC were associated with increased moxifloxacin treatment failure.
Mycoplasma genitalium prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019-2021.
Mutations in both 23S rRNA A2058/A2059 and ParC S83/D87
Mycoplasma genitalium antibiotic resistance-associated mutations in genital and extragenital samples from men-who-have-sex-with-men attending a STI clinic in Verona, Italy.
clinically relevant
Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study.
Global analysis on the mutations associated with multidrug-resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta-analysis.
mutations in parC gene associated with fluoroquinolone resistance
In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium.
Performance of the first commercial dual resistance assay, AmpliSens Mycoplasma genitalium-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of M. genitalium resistance mutations in St. Petersburg, Russia.
Rapid Detection of Antimicrobial Resistance in Mycoplasma genitalium by High-Resolution Melting Analysis with Unlabeled Probes.
Mutations in the parC gene are responsible for fluoroquinolone resistance in Mycoplasma genitalium.
In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.
Mycoplasma genitalium parC mutations confers resistance to Moxifloxacin; CARD accession: CARD:3004630
Interactions between Zoliflodacin and Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting.
Mutations in parC reduce susceptibility to zoliflodacin.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research